Hikma Pharmaceuticals PLC HIK shares slipped 1.68% to £19.86 Monday, on what proved to be an all-around rough trading session ...
LONDON - Hikma Pharmaceuticals (OTC:HKMPY) PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday ...
In a report released today, James Gordon from J.P. Morgan reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report). The company’s shares opened today at p2,154.00. See what ...
In a report released yesterday, Victoria Lambert from Berenberg Bank maintained a Buy rating on Hikma Pharmaceuticals (HIK – Research Report), with a price target of p2,560.00. The company’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results